Astellas Steps Tentatively Into Global Vaccines, Following Path Of Japanese Competitors
This article was originally published in The Pink Sheet Daily
Executive Summary
Astellas Pharma is making forays into the vaccines segment, with the support of development firm ClearPath Development Company to accelerate the process.